SWM
StoneCrest Wealth Management’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Sell |
25,070
-637
| -2% | -$8.91K | 0.17% | 64 |
|
|
2025
Q1 | $347K | Sell |
25,707
-152
| -0.6% | -$2.05K | 0.22% | 60 |
|
|
2024
Q4 | $496K | Sell |
25,859
-1,734
| -6% | -$33.2K | 0.32% | 48 |
|
|
2024
Q3 | $628K | Buy |
27,593
+109
| +0.4% | +$2.48K | 0.46% | 39 |
|
|
2024
Q2 | $358K | Sell |
27,484
-191
| -0.7% | -$2.49K | 0.27% | 48 |
|
|
2024
Q1 | $485K | Sell |
27,675
-116
| -0.4% | -$2.03K | 0.42% | 39 |
|
|
2023
Q4 | $605K | Buy |
+27,791
| New | +$605K | 0.58% | 34 |
|